Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-25 @ 2:22 AM
Ignite Modification Date:
2025-12-25 @ 2:22 AM
NCT ID:
NCT02751034
Brief Summary:
The purpose of this study is to compare the efficacy and safety of the study medical device, Neuramis® Deep Lidocaine and the control medical device, Restylane® PERLANE-L in correction of nasolabial folds
Detailed Description:
This study is a multi-center, double blind, intra-individual controlled, active-controlled clinical trial.
Efficacy and Safety are evaluated at the appointed time at subject visit clinical site after Injecting medical device.
Study:
NCT02751034
Study Brief:
Protocol Section:
NCT02751034